How Europe's largest not-for-profit health insurance fund is planningdisease management initiatives was discussed at last month's PharmEcon Europe 97 conference (Marketletters passim), organized by ICBI.
The company is Barmer Ersatzkasse, Germany's largest health insurance fund, which insures about 9.6 million lives, with a market share of 12%, or 13.3% of the population covered by statutory health insurance.
Gerd Glaeske, head of Barmer's department of research and strategies in health care management, said that Germany's 1993 health reform introduced a new element of competition into statutory health insurance, in that a free choice of fund for all members replaced the traditional profession-based membership. Once a year, members are entitled to change to any statutory fund of their choice.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze